Disproportionate increases seen across Black and Hispanic individuals, particularly in opioid-stimulant and opioid-only profiles.

Bernie Sanders, found that drug companies involved in price deals with President Donald Trump have continued to raise prices on hundreds of medications. Some new drugs are also launching with very ...

No increase seen in incidence of major bleeding, adverse events, or serious adverse events compared with placebo.

Difference largest in acute low back pain case, but lower scores were seen across five standardized care cases ...

Alkylating and platinating agent exposure in childhood cancer survivors is associated with impaired spermatogenesis and azoospermia.

MRI-guided transurethral ultrasound ablation associated with less blood loss, shorter stays, and less pain than robotic prostatectomy.

A trial compared patient-reported outcome measures after percutaneous nephrostomy vs JJ ureteric stent for urinary tract decompression in patients with obstructive stones.

FDA grants Priority Review to enfortumab vedotin plus pembrolizumab for cisplatin-eligible MIBC based on KEYNOTE-B15 data showing a 47% reduction in EFS risk.

For those diagnosed by age 16 years, younger age at diagnosis linked to higher GPA, lower probability of school dropout.

(HealthDay News) — Social media posts about glucagon-like peptide-1 receptor agonists may identify patient concerns not captured in clinical trials, according to a study published online April 10 in ...

The FDA is encouraging TRT manufacturers to seek a new indication for low libido in men with idiopathic hypogonadism.

Orforglipron was noninferior to insulin glargine regarding the time to first MACE-4 event in adults with type 2 diabetes and obesity or overweight.